版本:
中国

BRIEF-Immune Pharma signs LOI with Pint Pharma

April 20 Immune Pharmaceuticals Inc

* Immune pharmaceuticals signs letter of intent with pint pharma regarding license and commercializion of ceplene® in latin america

* Immune pharmaceuticals -entered into a letter of intent with pint pharma gmnh, a pharmaceutical company focused on latin america and other markets Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐